Aug 12 -- The Centers for Disease Control and Prevention (CDC) invites comments to OMB by September 15, 2022 on the Well-Integrated Screening and Evaluation for Women Across the Nation Reporting System (WISEWOMAN).
The WISEWOMAN program, sponsored by the CDC, provides services to low income, uninsured, or underinsured women aged 40-64. WISEWOMAN is designed to prevent, detect, and control hypertension and other cardiovascular disease (CVD) risk factors through healthy behavior support services which are tailored for individual and group behavior change. The WISEWOMAN program provides services to women who are jointly enrolled in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which is also sponsored by CDC.
The WISEWOMAN program is administered by state health departments and tribal programs. In 2018, new five-year cooperative agreements were awarded under Funding Opportunity Announcement DP18-1816, subject to the availability of funds. CDC collects two types of information from WISEWOMAN awardees. The WISEWOMAN awardee submits an electronic data file to CDC twice per year. The Minimum Data Elements (MDE) file contains data using a unique identifier with client-level information about cardiovascular disease risk factors and types of healthy behavior support services for participants served by the program. The estimated burden per response for the MDE file is 24 hours. In addition, each WISEWOMAN awardee submits an Annual Progress Report to CDC, which provides a narrative summary of the awardee's objectives and the activities undertaken to meet program goals. The estimated burden per response for the Annual Progress Report is 16 hours.
There are no changes to the information collection. CDC will continue to use the information collected from WISEWOMAN awardees to support program monitoring and improvement activities, evaluation, and assessment of program outcomes. The overall program evaluation helps to demonstrate program accomplishments and strengthen the evidence for implementing strategies that improve engagement of underserved populations. The information reported to CDC can also help to determine whether the identified strategies and associated activities can be implemented at various levels within a state or tribal organization. Evaluation is also designed to demonstrate how WISEWOMAN can obtain cardiovascular disease health outcome data on at-risk populations, promote public education about cardiovascular disease risk-factors, and improve the availability of healthy behavior support services for under-served women.
CDC WISEWOMAN Program: https://www.cdc.gov/wisewoman/index.htm
Submission to OMB: https://www.reginfo.gov/public/do/PRAViewICR?ref_nbr=202208-0920-002
Click on IC List for collection instruments, View Supporting Statement for technical documentation. Submit comments through this site.
FR notice inviting public comment: https://www.federalregister.gov/d/2022-17360
For AEA members wishing to submit comments, "A Primer on How to Respond to Calls for Comment on Federal Data Collections" is available at https://www.aeaweb.org/content/file?id=5806